baricitinib
eli lilly
[' bari ', 'baricitinib']
congress #ash22 | mark a schroeder discusses a phase i study of baricitinib as gvhd prophylaxis in hla-matched pbsc-hct. n=24. trm at d180 was 8%. the ci of grade iii/iv agvhd at day 100 =4% &amp; the overall incidence of grade iii/iv agvhd at any time =12.5% #gvhd #bmtsm 
A global online platform providing latest treatment options and medical information in graft-versus-host disease (GvHD). #gvhd